Advertisement

Topics

Viking nets $72.6mm via FOPO

19:41 EDT 8 Jun 2018 | Elsevier Business Intelligence

In its second FOPO in four months, Viking Therapeutics Inc. (developing therapies for metabolic and endocrine disorders) nett...

Original Article: Viking nets $72.6mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "Viking nets $72.6mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...